View Older Stories

Feb 29, 2024 11:43AM Endo Reaches Resolution with U.S. Department of Justice Regarding Legacy Marketing of Opana® ER

Jan 24, 2024 07:31AM Endo International (ENDPQ) Reports Publication of New XIAFLEX Survey Data

Jan 24, 2024 07:30AM Endo Announces Publication of New XIAFLEX® (collagenase clostridium histolyticum) Survey Data in Journal of Hand Surgery Global Open

Jan 22, 2024 04:31PM Endo's (ENDPQ) Paladin Labs Announces Launch of XCOPRI in Canada

Jan 22, 2024 04:30PM Endo's Paladin Labs Announces Launch of XCOPRI® (cenobamate tablets) in Canada

Jan 19, 2024 07:30AM Endo Announces New Data for Dupuytren's Contracture Presented at the American Association for Hand Surgery Annual Meeting

Dec 19, 2023 01:30PM Endo International (ENDPQ) Files Plan of Reorganization to Implement Previously Announced Sale Transaction

Dec 19, 2023 01:27PM ENDO FILES PLAN OF REORGANIZATION TO IMPLEMENT PREVIOUSLY ANNOUNCED SALE TRANSACTION

Nov 30, 2023 07:30AM Endo Launches Unscripted Video Series With Real Peyronie's Disease Patients

Nov 16, 2023 07:30AM Endo Announces Five Presentations at the Sexual Medicine Society of North America (SMSNA) Annual Meeting

Nov 6, 2023 04:05PM ENDO REPORTS THIRD-QUARTER 2023 FINANCIAL RESULTS

Nov 2, 2023 07:31AM Endo International (ENDPQ) Launches Colchicine Capsules

Nov 2, 2023 07:30AM Endo Launches Colchicine Capsules, Generic Version of MITIGARE®

Sep 21, 2023 07:45AM Endo Presents New Data at the American Orthopaedic Foot & Ankle Society Annual Meeting

Aug 8, 2023 07:45AM ENDO REPORTS SECOND-QUARTER 2023 FINANCIAL RESULTS

Jul 20, 2023 07:30AM Endo Announces First Patient Enrolled in Registry of Peyronie's Disease

Jul 18, 2023 04:31PM Endo International (ENDPQ) Launches Bivalirudin Injection in Ready-to-Use Vials

Jul 18, 2023 04:30PM Endo Launches Bivalirudin Injection in Ready-to-Use Vials

Jul 17, 2023 04:31PM Endo International (ENDPQ) and Premier (PINC) Collaborate to Address Pitocin Shortage

Jul 17, 2023 04:30PM Endo and Premier, Inc. Collaborate to Address Pitocin® (oxytocin injection, USP) Shortage

Jul 13, 2023 04:30PM Endo Presents New Data at the American Podiatric Medical Association Annual Meeting

Jun 29, 2023 04:30PM Endo Launches First Generic Version of Noxafil® (posaconazole) Injection

Jun 29, 2023 07:30AM Endo International (ENDPQ) Announces Approval of XCOPRI in Canada

Jun 29, 2023 07:30AM Endo Announces Approval of XCOPRI™ (cenobamate tablets) in Canada

Jun 26, 2023 07:30AM Endo Announces First Patient Enrolled in Registry of Dupuytren's Contracture

Jun 15, 2023 07:30AM Endo International (ENDPQ) Launches Dexlansoprazole Capsules, Generic Version of Dexilant

Jun 15, 2023 07:30AM Endo Launches Dexlansoprazole Capsules, Generic Version of Dexilant®

Jun 12, 2023 07:30AM Endo Launches PREVDUO™ (neostigmine methylsulfate and glycopyrrolate injection), the First and Only FDA-Approved Neostigmine-Glycopyrrolate Combination Pre-Filled Syringe

Jun 5, 2023 07:31AM Endo International (ENDPQ) Announces Publication of XIAFLEX Data Analysis

Jun 5, 2023 07:30AM Endo Announces Publication of XIAFLEX® (collagenase clostridium histolyticum) Data Analysis in Peer-Reviewed Urology®

May 24, 2023 07:30AM Endo Announces Agreement with MAIA Pharmaceuticals to Distribute Bivalirudin Injection in Ready-to-Use Vials

May 8, 2023 07:30AM ENDO REPORTS FIRST-QUARTER 2023 FINANCIAL RESULTS

Apr 26, 2023 07:30AM Endo Announces Agreement with Slayback Pharma to Distribute Prevduo™ (neostigmine methylsulfate and glycopyrrolate injection), the First and Only FDA-Approved Neostigmine-Glycopyrrolate Combination

Apr 17, 2023 07:45AM Endo Announces Launch of Argatroban Injection Through Premier's ProRx® Private-Label Program

Apr 3, 2023 04:30PM Endo Launches Authorized Generic Version of Noxafil® (posaconazole) Oral Suspension

Mar 13, 2023 04:15PM Endo Provides Top-Line Results from Phase 2 Study of Collagenase Clostridium Histolyticum (CCH) in Participants With Plantar Fibromatosis

Mar 10, 2023 07:30AM Endo Launches First Generic Version of Pylera® (bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride) Capsules

Mar 6, 2023 08:50AM ENDO REPORTS FOURTH-QUARTER 2022 FINANCIAL RESULTS

Feb 6, 2023 07:30AM Endo Launches "Man With a Plan" Campaign to Support Men With Symptoms of Peyronie's Disease

Dec 6, 2022 04:45PM Endo to Cease Production and Sale of Qwo® (collagenase clostridium histolyticum-aaes)

Nov 9, 2022 08:30AM ENDO REPORTS THIRD-QUARTER 2022 FINANCIAL RESULTS

Oct 27, 2022 07:30AM Endo and SMSNA Launch App to Provide Peyronie's Disease Self-Assessment Tool

Oct 7, 2022 07:30AM Endo Presents New Qwo® (collagenase clostridium histolyticum-aaes) Data at the American Society for Dermatologic Surgery's Annual Meeting

Oct 5, 2022 07:30AM Endo Launches Unscripted Video Series With Real Dupuytren's Contracture Patients

View Older Stories